IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM DOI Creative Commons
Μαρκέλλα Ζαννίκου, Joseph Duffy, Rebecca Levine

et al.

Journal for ImmunoTherapy of Cancer, Journal Year: 2023, Volume and Issue: 11(2), P. e006239 - e006239

Published: Feb. 1, 2023

Introduction The immunosuppressive tumor microenvironment (TME) is a major barrier to the efficacy of chimeric antigen receptor T cells (CAR-T cells) in glioblastoma (GBM). Transgenic expression IL15 one attractive strategy modulate TME. However, at present, it unclear if could be used directly target myeloid-derived suppressor (MDSCs), cellular component GBM Here, we explored MDSC express IL15Rα and feasibility exploiting its as an immunotherapeutic target. Methods RNA-seq, RT-qPCR, flow cytometry were determine paired peripheral tumor-infiltrating immune patients two syngeneic murine models. We generated expressing IL13Rα2-CARs secretory (CAR.IL15s) or which was fused CAR serve IL15Rα-targeting moiety (CAR.IL15f), characterized their effector function vitro IL13Rα2+glioma Results preferentially expressed myeloid, B, dendritic patients’ GBMs. In vitro, CAR.IL15s CAR.IL15f depleted decreased secretion molecules with being more efficacious. Similarly, significantly improved survival mice TME analysis showed that treatment resulted higher frequencies CD8+T cells, NK, B but decrease CD11b+cells tumors compared therapy cells. Conclusions demonstrate glioma IL15Ra these can targeted incorporated into CAR. Thus, IL15-modified act dual targeting agent against GBM, warranting future evaluation early-phase clinical studies.

Language: Английский

Therapeutic Targeting of the Tumor Microenvironment DOI Open Access
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce

et al.

Cancer Discovery, Journal Year: 2021, Volume and Issue: 11(4), P. 933 - 959

Published: April 1, 2021

Abstract Strategies to therapeutically target the tumor microenvironment (TME) have emerged as a promising approach for cancer treatment in recent years due critical roles of TME regulating progression and modulating response standard-of-care therapies. Here, we summarize current knowledge regarding most advanced TME-directed therapies, which either been clinically approved or are currently being evaluated trials, including immunotherapies, antiangiogenic drugs, treatments directed against cancer-associated fibroblasts extracellular matrix. We also discuss some challenges associated with future perspectives this evolving field. Significance: This review provides comprehensive analysis therapies targeting TME, combining discussion underlying basic biology clinical evaluation different therapeutic approaches, highlighting perspectives.

Language: Английский

Citations

1093

The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease DOI Creative Commons
Guillermo Oliver, Jonathan Kipnis, Gwendalyn J. Randolph

et al.

Cell, Journal Year: 2020, Volume and Issue: 182(2), P. 270 - 296

Published: July 1, 2020

Language: Английский

Citations

529

Functional characterization of the dural sinuses as a neuroimmune interface DOI
Justin Rustenhoven, Antoine Drieu, Tornike Mamuladze

et al.

Cell, Journal Year: 2021, Volume and Issue: 184(4), P. 1000 - 1016.e27

Published: Jan. 27, 2021

Language: Английский

Citations

468

Fluid transport in the brain DOI
Martin Kaag Rasmussen, Humberto Mestre, Maiken Nedergaard

et al.

Physiological Reviews, Journal Year: 2021, Volume and Issue: 102(2), P. 1025 - 1151

Published: May 5, 2021

The brain harbors a unique ability to, figuratively speaking, shift its gears. During wakefulness, the is geared fully toward processing information and behaving, while homeostatic functions predominate during sleep. blood-brain barrier establishes stable environment that optimal for neuronal function, yet imposes physiological problem; transcapillary filtration forms extracellular fluid in other organs reduced to minimum brain. Consequently, depends on special [the cerebrospinal (CSF)] flushed into along perivascular spaces created by astrocytic vascular endfeet. We describe this pathway, coined term glymphatic system, based dependency endfeet their adluminal expression of aquaporin-4 water channels facing CSF-filled spaces. Glymphatic clearance potentially harmful metabolic or protein waste products, such as amyloid-β, primarily active sleep, when drivers, cardiac cycle, respiration, slow vasomotion, together efficiently propel CSF inflow periarterial brain's space contains an abundance proteoglycans hyaluronan, which provide low-resistance hydraulic conduit rapidly can expand shrink sleep-wake cycle. system brain, meets requisites maintain homeostasis similar peripheral organs, considering blood-brain-barrier paths formation egress CSF.

Language: Английский

Citations

340

Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics DOI Creative Commons
Steven T. Proulx

Cellular and Molecular Life Sciences, Journal Year: 2021, Volume and Issue: 78(6), P. 2429 - 2457

Published: Jan. 11, 2021

Abstract Cerebrospinal fluid (CSF) is produced by the choroid plexuses within ventricles of brain and circulates through subarachnoid space skull spinal column to provide buoyancy maintain homeostasis cord. The question how CSF drains from has long puzzled scientists clinicians. For many decades, it was believed that arachnoid villi or granulations, outcroppings tissue project into dural venous sinuses, served as major outflow route. However, this concept been increasingly challenged in recent years, physiological imaging evidence several species accumulated showing tracers injected can instead be found lymphatic vessels draining cranium spine. With high-profile rediscovery meningeal located dura mater, another debate emerged regarding exact anatomical pathway(s) for reach system, with one side favoring direct efflux advocating pathways along exiting cranial nerves. In review, a summary historical contemporary different will presented, allowing reader gain further perspective on advances field. An improved understanding fundamental process may lead novel therapeutic approaches wide range neurological conditions, including hydrocephalus, neurodegeneration multiple sclerosis.

Language: Английский

Citations

266

Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis DOI Creative Commons
Ashley C. Bolte, Arun B. Dutta,

Mariah E. Hurt

et al.

Nature Communications, Journal Year: 2020, Volume and Issue: 11(1)

Published: Sept. 10, 2020

Abstract Traumatic brain injury (TBI) is a leading global cause of death and disability. Here we demonstrate in an experimental mouse model TBI that mild forms trauma severe deficits meningeal lymphatic drainage begin within hours last out to at least one month post-injury. To investigate mechanism underlying impaired function TBI, examined how increased intracranial pressure (ICP) influences the lymphatics. We ICP can contribute dysfunction. Moreover, show pre-existing dysfunction before leads neuroinflammation negative cognitive outcomes. Finally, report rejuvenation aged mice ameliorate TBI-induced gliosis. These findings provide insights into both causes consequences suggest therapeutics targeting system may offer strategies treat TBI.

Language: Английский

Citations

249

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection DOI
Jing Zhang, Chen Chen, Anning Li

et al.

Nature Nanotechnology, Journal Year: 2021, Volume and Issue: 16(5), P. 538 - 548

Published: Feb. 1, 2021

Language: Английский

Citations

232

Pathological angiogenesis: mechanisms and therapeutic strategies DOI Creative Commons
Andrew C. Dudley, Arjan W. Griffioen

Angiogenesis, Journal Year: 2023, Volume and Issue: 26(3), P. 313 - 347

Published: April 15, 2023

In multicellular organisms, angiogenesis, the formation of new blood vessels from pre-existing ones, is an essential process for growth and development. Different mechanisms such as vasculogenesis, sprouting, intussusceptive, coalescent well vessel co-option, vasculogenic mimicry lymphangiogenesis, underlie vasculature. many pathological conditions, cancer, atherosclerosis, arthritis, psoriasis, endometriosis, obesity SARS-CoV-2(COVID-19), developmental angiogenic processes are recapitulated, but often done so without normal feedback that regulate ordinary spatial temporal patterns formation. Thus, angiogenesis presents challenges yet opportunities design vascular-directed therapies. Here, we provide overview recent insights into development highlight novel therapeutic strategies promote or inhibit to stabilize, reverse, even halt disease progression. our review, will also explore several additional aspects (the switch, hypoxia, angiocrine signals, endothelial plasticity, normalization, cell anergy) operate in parallel canonical speculate how these may be targeted with anti-angiogenic

Language: Английский

Citations

227

Tumor-draining lymph nodes: At the crossroads of metastasis and immunity DOI
Haley du Bois, Taylor A. Heim, Amanda W. Lund

et al.

Science Immunology, Journal Year: 2021, Volume and Issue: 6(63)

Published: Sept. 3, 2021

Early engagement of the lymphatic system by solid tumors in peripheral, nonlymphoid tissues is a clinical hallmark cancer and often forecasts poor prognosis. The significance lymph node metastasis for distant spread, however, has been questioned large-scale dissection trials likely prevalence direct hematogenous metastasis. Still, an emerging appreciation immunological role tumor-draining renewed interest its basic biology, metastatic progression, antitumor immunity, patient outcomes. In this review, we discuss our current understanding early mechanisms through which engage transport condition nodes, these changes both potential implications immunotherapy.

Language: Английский

Citations

189

Challenges in glioblastoma research: focus on the tumor microenvironment DOI Creative Commons
Andréas Bikfalvi, Cristine Alvès da Costa, Tony Avril

et al.

Trends in cancer, Journal Year: 2022, Volume and Issue: 9(1), P. 9 - 27

Published: Nov. 16, 2022

Language: Английский

Citations

171